PMID- 35761309 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220716 IS - 1758-5996 (Print) IS - 1758-5996 (Electronic) IS - 1758-5996 (Linking) VI - 14 IP - 1 DP - 2022 Jun 27 TI - Targeting ferroptosis with miR-144-3p to attenuate pancreatic beta cells dysfunction via regulating USP22/SIRT1 in type 2 diabetes. PG - 89 LID - 10.1186/s13098-022-00852-7 [doi] LID - 89 AB - BACKGROUND: Recently, ferroptosis has been implicated in the pathologic process of several diseases including type 2 diabetes mellitus (T2DM). However, molecular mechanisms underlying ferroptosis in T2DM remain obscure. METHODS: Twenty four mice were included in this study. T2DM model mice were established by a high-fat diet combined with streptozotocin injection. INS-1 cells were stimulated with high glucose (HG). Cell viability was detected by CCK-8 kit. The levels of GSH, MDA, iron, and lipid ROS, and SOD activity, were detected by the corresponding kits. The interaction between miR-144-3p and USP22 was validated by dual-luciferase reporter assay. The relationship between USP22 and its substrate was verified using Co-IP and ubiquitination assays. The mRNA and protein expressions were examined by RT-qPCR and western blot, respectively. The functions of beta cells in vitro and in vivo were evaluated glucose-stimulated insulin secretion test and HOMA-beta, respectively. RESULTS: Ferroptosis occurred in the pancreas of T2DM mice and HG-induced INS-1 cells. Silencing miR-144-3p blocked the effect of HG on the cell viability and accumulation of lipid peroxides, thereby improving the insulin secretion in INS-1 cells. Mechanistically, USP22 is a direct target of miR-144-3p, which could stabilize SIRT1 expression, thereby suppressing ferroptosis. Overexpressing USP22 attenuated deleterious roles of HG in INS-1 cells; but its roles were reversed by up-regulating miR-144-3p. In vivo study demonstrated that miR-144-3p antagomir exerted an anti-hyperglycemic effect and regulated the ferroptosis-related proteins in the pancreas. CONCLUSION: The up-regulation of miR-144-3p suppressed USP22/SIRT1 to induce ferroptosis, which causes pancreatic beta cells dysfunction, thereby promoting T2DM development. CI - (c) 2022. The Author(s). FAU - Zhang, Shanshan AU - Zhang S AD - School of Medicine of Pingdingshan University, Middle Section of Chongwen Road, Xincheng District, Pingdingshan, 467000, Henan, China. AD - Shool of Nursing, Doctor of Philosophy in Nursing, Philippine Women's University, Manila, Philippines. FAU - Liu, Xiao AU - Liu X AD - School of Medicine of Pingdingshan University, Middle Section of Chongwen Road, Xincheng District, Pingdingshan, 467000, Henan, China. sszh.baobao@163.com. AD - Shool of Nursing, Doctor of Philosophy in Nursing, Philippine Women's University, Manila, Philippines. sszh.baobao@163.com. FAU - Wang, Jihong AU - Wang J AD - School of Medicine of Pingdingshan University, Middle Section of Chongwen Road, Xincheng District, Pingdingshan, 467000, Henan, China. 799981507@qq.com. FAU - Yuan, Fengjuan AU - Yuan F AD - School of Medicine of Pingdingshan University, Middle Section of Chongwen Road, Xincheng District, Pingdingshan, 467000, Henan, China. AD - Shool of Nursing, Doctor of Philosophy in Nursing, Philippine Women's University, Manila, Philippines. FAU - Liu, Yali AU - Liu Y AD - School of Medicine of Pingdingshan University, Middle Section of Chongwen Road, Xincheng District, Pingdingshan, 467000, Henan, China. AD - Shool of Nursing, Doctor of Philosophy in Nursing, Philippine Women's University, Manila, Philippines. LA - eng GR - wjlx2020293/medical education research project of Henan Province, based on the construction of the elderly nursing technology curriculum system based on the post competency training of elderly nursing talents, project number/ GR - jpzx19247/Pingdingshan University Health Assessment School-level Excellent Online Open Course/ PT - Journal Article DEP - 20220627 PL - England TA - Diabetol Metab Syndr JT - Diabetology & metabolic syndrome JID - 101488958 PMC - PMC9235078 OTO - NOTNLM OT - Ferroptosis OT - Pancreatic beta cells OT - Type 2 diabetes mellitus OT - USP22 OT - miR-144-3p COIS- The authors declare that they have no competing interests. EDAT- 2022/06/28 06:00 MHDA- 2022/06/28 06:01 PMCR- 2022/06/27 CRDT- 2022/06/27 23:45 PHST- 2022/02/15 00:00 [received] PHST- 2022/05/30 00:00 [accepted] PHST- 2022/06/27 23:45 [entrez] PHST- 2022/06/28 06:00 [pubmed] PHST- 2022/06/28 06:01 [medline] PHST- 2022/06/27 00:00 [pmc-release] AID - 10.1186/s13098-022-00852-7 [pii] AID - 852 [pii] AID - 10.1186/s13098-022-00852-7 [doi] PST - epublish SO - Diabetol Metab Syndr. 2022 Jun 27;14(1):89. doi: 10.1186/s13098-022-00852-7.